+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Electrophysiology Devices: Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5028117

Global Electrophysiology Devices Market to Reach $16.1 Billion by 2030

The global market for Electrophysiology Devices estimated at US$8.6 Billion in the year 2022, is projected to reach a revised size of US$16.1 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2022-2030. Electrophysiology Ablation Catheters, one of the segments analyzed in the report, is projected to record 9.3% CAGR and reach US$6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electrophysiology Diagnostic Catheters segment is readjusted to a revised 7.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 7.6% CAGR

The Electrophysiology Devices market in the U.S. is estimated at US$2.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories, Inc.
  • Biosense Webster, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Stereotaxis, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Electrophysiology Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Electrophysiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Electrophysiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Electrophysiology Laboratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Electrophysiology Laboratory Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Electrophysiology Laboratory Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Electrophysiology Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Electrophysiology Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Electrophysiology Ablation Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Electrophysiology Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Electrophysiology Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Electrophysiology Diagnostic Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Atrial Fibrillation (AF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Atrial Fibrillation (AF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Atrial Fibrillation (AF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Atrial Flutter (AFL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Atrial Flutter (AFL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Atrial Flutter (AFL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Atrioventricular Nodal Reentrant Tachycardia (AVNRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 28: World Electrophysiology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 29: World Recent Past, Current & Future Analysis for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 30: World Historic Review for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: World 16-Year Perspective for Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 32: USA Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: USA Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: USA 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 35: USA Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: USA Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: USA 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
CANADA
  • Table 38: Canada Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Canada 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Canada 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
JAPAN
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 44: Japan Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Japan 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 47: Japan Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Japan 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
CHINA
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 50: China Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: China Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: China 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 53: China Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: China Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: China 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
EUROPE
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 56: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Electrophysiology Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: Europe 16-Year Perspective for Electrophysiology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: Europe 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Europe 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
FRANCE
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 65: France Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: France Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: France 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 68: France Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: France Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: France 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
GERMANY
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 71: Germany Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: Germany 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 74: Germany Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: Germany Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: Germany 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
ITALY
  • Table 77: Italy Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: Italy 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 80: Italy Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Italy Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: Italy 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 83: UK Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: UK Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: UK 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 86: UK Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: UK Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: UK 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Electrophysiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Electrophysiology Devices by Product - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Electrophysiology Devices by Product - Percentage Breakdown of Value Sales for Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices and Other Products for the Years 2014, 2023 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Electrophysiology Devices by Indication - Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Electrophysiology Devices by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation (AF), Atrial Flutter (AFL), Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications for the Years 2014, 2023 & 2030
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • Biosense Webster, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Stereotaxis, Inc.

Table Information